High-grade gliomas may be able to wire themselves into the healthy brain, receiving and interpreting electrical signals from normal neurons.
This week in industry includes trials on elenbecestat to be discontinued, ofatumumab demonstrating superiority to Aubagio and the Toca 5 trial results failing to meet primary endpoint.
In a large data study, researchers discover that terazosin, a drug typically used to treat enlarged prostate, might be able to slow down neurodegeneration in Parkinson’s disease.
A research team has discovered that metformin promotes repair in the brains of adult female mice and that the female sex hormone estradiol plays a key role in this process.
Researchers have utilized flortaucipir PET to identify tau protein tangles in the brains of individuals who have suffered just a single head injury.
Left-handed people have been reported to have certain genetic regions that are associated with brain architecture in areas involved with language.
In the largest study of its kind, researchers discovered that testosterone does not impair cognitive empathy, challenging the notion of autism as reflecting an ‘extreme male brain’.
What have been the biggest headlines in industry this week? Take a look at our highlights including positive news about two monoclonal antibodies for relapsing multiple sclerosis and neuromyelitis optica spectrum disorder.
Researchers have developed ’mini-brains’ with optimized cellular network activity, which exhibit similar electrical impulse patterns observed in premature infants.